- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02249390
Assisted Reproductive Technology Survey (ART Survey) (ART)
September 26, 2022 updated by: Leanne Redman, Pennington Biomedical Research Center
ART Survey: Assisted Reproductive Technology Survey
The purpose of the study is to collate local information to better understand the motivations, accessibility and frequency of assisted reproductive technology (ART) use in the community.
Study Overview
Status
Completed
Detailed Description
The ART survey study recruitment will last about 6 months with the study completed within 1 year. Study participation is an online survey which takes approximately 3 minutes to complete.
The goal is to apply for future funding to study the metabolic consequences of being conceived with ART.
Study Type
Observational
Enrollment (Actual)
336
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pennington Biomedical Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects will be recruited from the community.
Parents of children who have participated in a research study at Pennington Biomedical Research Center or patients from local fertility clinics.
Description
Inclusion Criteria:
- Any individual may complete this survey
Exclusion Criteria:
- No exclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Anyone
Any individual may complete this survey
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Method of Conception
Time Frame: 1 year
|
ART Survey
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Leanne M Redman, MS, PHD, Pennington Biomedical Research Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
April 1, 2017
Study Completion (Actual)
April 1, 2017
Study Registration Dates
First Submitted
September 18, 2014
First Submitted That Met QC Criteria
September 24, 2014
First Posted (Estimate)
September 25, 2014
Study Record Updates
Last Update Posted (Actual)
September 27, 2022
Last Update Submitted That Met QC Criteria
September 26, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- PBRC 2014-042
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Female Reproductive Problem
-
University Hospital, ToulouseTerminatedFemale Reproductive Problem | Male Reproductive ProblemsFrance
-
Queensland Centre for Gynaecological CancerCompletedFemale Reproductive ProblemAustralia
-
IVI MadridInstituto Valenciano de Infertilidad, IVI VALENCIA; Instituto Valenciano de...Unknown
-
Jimma UniversityCompletedMale Reproductive ProblemEthiopia
-
European Institute of OncologyUnknownFemale Reproductive CancerItaly
-
University of SaskatchewanCanadian Institutes of Health Research (CIHR)Completed
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingMetastatic Malignant Female Reproductive System Neoplasm | Platinum-Resistant Malignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingMalignant Female Reproductive System NeoplasmUnited States
-
Seoul National University Bundang HospitalUnknownMalignant Female Reproductive System NeoplasmKorea, Republic of
-
Liu WeifengNanfang Hospital of Southern Medical University; Second Affiliated Hospital... and other collaboratorsCompletedBenign Female Reproductive System NeoplasmChina